Ozgur, E. Et Al. 2017. PCA3 Silencing Sensitizes Prostate Cancer Cells to Enzalutamide-mediated Androgen Receptor Blockade. ANTICANCER RESEARCH , vol.37, no.7 , 3631-3637.

Ozgur, E., Celik, A. I., Darendeliler, E., & Gezer, U., (2017). PCA3 Silencing Sensitizes Prostate Cancer Cells to Enzalutamide-mediated Androgen Receptor Blockade. ANTICANCER RESEARCH , vol.37, no.7, 3631-3637.

Ozgur, Emre Et Al. "PCA3 Silencing Sensitizes Prostate Cancer Cells to Enzalutamide-mediated Androgen Receptor Blockade," ANTICANCER RESEARCH , vol.37, no.7, 3631-3637, 2017

Ozgur, Emre Et Al. "PCA3 Silencing Sensitizes Prostate Cancer Cells to Enzalutamide-mediated Androgen Receptor Blockade." ANTICANCER RESEARCH , vol.37, no.7, pp.3631-3637, 2017

Ozgur, E. Et Al. (2017) . "PCA3 Silencing Sensitizes Prostate Cancer Cells to Enzalutamide-mediated Androgen Receptor Blockade." ANTICANCER RESEARCH , vol.37, no.7, pp.3631-3637.

@article{article, author={Emre ÖZGÜR Et Al. }, title={PCA3 Silencing Sensitizes Prostate Cancer Cells to Enzalutamide-mediated Androgen Receptor Blockade}, journal={ANTICANCER RESEARCH}, year=2017, pages={3631-3637} }